FDA Drug · D-1174-2022

Eszopiclone Tablets, USP 1 mg, packaged in 30-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, INDIA, NDC 33342-299-07

Class II · Terminated

Shortfill: customer complaints of one to three tablets were reported missing from 30 count bottles.

Affected lots / codes — check yours against thisLot #: BEK2009A Exp: 11/2023

Recalling firm: Macleods Pharma Usa Inc, Plainsboro, NJ
Classification: Class II (temporary or reversible harm possible)
Status: Terminated
Quantity: 168690 Tablets
Distribution: Distributed Nationwide and Puerto Rico.
Recall initiated: June 16, 2022
Classified: July 5, 2022
Terminated: March 20, 2024
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1174-2022%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →